ES2145118T3 - Derivados de acidos grasos y composiciones farmaceuticas que los contienen. - Google Patents
Derivados de acidos grasos y composiciones farmaceuticas que los contienen.Info
- Publication number
- ES2145118T3 ES2145118T3 ES94903364T ES94903364T ES2145118T3 ES 2145118 T3 ES2145118 T3 ES 2145118T3 ES 94903364 T ES94903364 T ES 94903364T ES 94903364 T ES94903364 T ES 94903364T ES 2145118 T3 ES2145118 T3 ES 2145118T3
- Authority
- ES
- Spain
- Prior art keywords
- derivatives
- fatty acids
- pharmaceutical compositions
- contain
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/20—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a carbon atom of an acyclic unsaturated carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
- C07C233/09—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to carbon atoms of an acyclic unsaturated carbon skeleton
Abstract
AMIDAS DE ACIDOS GRASOS POLIINSATURADOS PUROS Y SUS DERIVADOS. ESTOS COMPUESTOS PRODUCIDOS SINTETICAMENTE SON CAPACES DE IMITAR DE FORMA NATURAL LA OCURRENCIA DE LAS ANANDAMIDAS EN LA MENTE Y UNIR EL RECEPTOR CANABINOIDE. LOS COMPUESTOS EXHIBEN ACTIVIDAD FISIOLOGICA Y SON UTILES COMO INGREDIENTES ACTIVOS EN COMPOSICIONES FARMACEUTICAS PARA EL TRATAMIENTO DE INFLAMACION, MIGRAÑAS, ACTIVIDAD DE ESPECTICIDAD, GLAUCOMA, ESCLEROSIS MULTIPLE. LOS COMPUESTOS ACTIVOS PUEDEN PROPORCIONARSE EN FORMA DE ISOTOPO MARCADO.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL10393292A IL103932A (en) | 1992-11-30 | 1992-11-30 | Fatty acid and pharmaceutical compositions containing them |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2145118T3 true ES2145118T3 (es) | 2000-07-01 |
Family
ID=11064282
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES94903364T Expired - Lifetime ES2145118T3 (es) | 1992-11-30 | 1993-11-30 | Derivados de acidos grasos y composiciones farmaceuticas que los contienen. |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP0670826B1 (es) |
JP (1) | JPH08504195A (es) |
CN (1) | CN1097735A (es) |
AU (1) | AU5733494A (es) |
CZ (1) | CZ136195A3 (es) |
DE (1) | DE69328492T2 (es) |
ES (1) | ES2145118T3 (es) |
HU (1) | HUT73177A (es) |
IL (1) | IL103932A (es) |
PL (1) | PL309051A1 (es) |
SK (1) | SK70895A3 (es) |
WO (1) | WO1994012466A1 (es) |
ZA (1) | ZA938947B (es) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5631297A (en) * | 1994-07-11 | 1997-05-20 | Pate; David W. | Anandamides useful for the treatment of intraocular hypertension, ophthalmic compositions containing the same and methods of use of the same |
CA2192965C (en) * | 1994-07-11 | 2007-12-04 | David W. Pate | Anandamide analogue compositions and method of treating intraocular hypertension using same |
IT1271267B (it) * | 1994-12-14 | 1997-05-27 | Valle Francesco Della | Ammidi di acidi mono e bicarbossilici con amminoalcoli,selettivamente attive sul recettore periferico dei cannabinoidi |
DE19544635A1 (de) * | 1995-11-30 | 1997-06-05 | Boehringer Mannheim Gmbh | Neue Aminoalkoholderivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
DE19706903A1 (de) * | 1997-02-21 | 1998-08-27 | Bayer Ag | Verwendung von bekannten Agonisten des zentralen Cannabinoid-Rezeptors CB 1 |
ES2209417T3 (es) * | 1998-04-03 | 2004-06-16 | Yissum Research And Development Company Of The Hebrew University Of Jerusalem | Analogos de los cannabinoides endogenos sinteticos y sus usos. |
EP1645270B1 (en) * | 1998-05-29 | 2010-04-28 | Neurosciences Research Foundation Inc. | Control of pain with ANANDAMIDE |
US7589220B2 (en) | 1998-06-09 | 2009-09-15 | University Of Connecticut | Inhibitors of the anandamide transporter |
US7897598B2 (en) | 1998-06-09 | 2011-03-01 | Alexandros Makriyannis | Inhibitors of the anandamide transporter |
ES2372572T3 (es) | 1998-08-17 | 2012-01-23 | Senju Pharmaceutical Co., Ltd. | Agente para profilaxis y tratamiento de glaucoma. |
WO2000032200A1 (en) * | 1998-11-24 | 2000-06-08 | Alexandros Makriyannis | Cannabimimetic lipid amides as useful medications |
US7161016B1 (en) | 1998-11-24 | 2007-01-09 | University Of Connecticut | Cannabimimetic lipid amides as useful medications |
US7276613B1 (en) | 1998-11-24 | 2007-10-02 | University Of Connecticut | Retro-anandamides, high affinity and stability cannabinoid receptor ligands |
GB9923738D0 (en) * | 1999-10-07 | 1999-12-08 | Nestle Sa | Nutritional composition |
US7119108B1 (en) | 1999-10-18 | 2006-10-10 | University Of Connecticut | Pyrazole derivatives as cannabinoid receptor antagonists |
WO2001089589A1 (en) | 2000-05-23 | 2001-11-29 | The Regents Of The University Of California | A novel treatment for cough |
NO20006008L (no) | 2000-11-28 | 2002-05-29 | Thia Medica As | Fettsyreanaloger for behandling av inflammatoriske og autoimmune sykdommer |
US8449908B2 (en) | 2000-12-22 | 2013-05-28 | Alltranz, Llc | Transdermal delivery of cannabidiol |
WO2002080860A2 (en) | 2001-03-27 | 2002-10-17 | The Regents Of The University Of California | Methods, compounds, and compositions for reducing body fat and modulating fatty acid metabolism |
WO2003008632A1 (en) * | 2001-07-16 | 2003-01-30 | Hoegestaett Edward | Fatty acid conjugation as a method for screening of potentially bioactive substances |
WO2003075917A1 (en) | 2002-03-08 | 2003-09-18 | Signal Pharmaceuticals, Inc. | Combination therapy for treating, preventing or managing proliferative disorders and cancers |
JP2006517194A (ja) | 2002-06-06 | 2006-07-20 | イッサム リサーチ ディベロップメント カンパニー オブ ザ ヘブリュー ユニバーシティ オブ エルサレム | 骨成長を調節するための方法、組成物および製造物 |
ITMI20030210A1 (it) * | 2003-02-07 | 2004-08-08 | Res & Innovation Soc Coop A R L | Composti endocannabinoido-simili e loro impiego |
US7276608B2 (en) | 2003-07-11 | 2007-10-02 | Bristol-Myers Squibb Company | Tetrahydroquinoline derivatives as cannabinoid receptor modulators |
US7326706B2 (en) | 2003-08-15 | 2008-02-05 | Bristol-Myers Squibb Company | Pyrazine modulators of cannabinoid receptors |
IL160420A0 (en) | 2004-02-16 | 2004-07-25 | Yissum Res Dev Co | Treating or preventing diabetes with cannabidiol |
EP2020850A4 (en) * | 2006-05-01 | 2010-10-13 | Eastern Virginia Med School | NEW CANNABINOIDS AND METHOD FOR THEIR USE |
WO2008139263A2 (en) * | 2006-11-30 | 2008-11-20 | University Of Plymouth | Methods for slowing the progression of multiple sclerosis |
MX2010001242A (es) | 2007-07-30 | 2010-07-02 | Alltranz Inc | Profarmacos de canabidiol, composiciones que comprenden profarmacos de canabidiol y metodos para utilizar los mismos. |
EP2262763A2 (en) * | 2008-03-04 | 2010-12-22 | Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. | Compounds and methods of treating obesity |
EP2309858A4 (en) * | 2008-07-31 | 2011-09-14 | Dekel Pharmaceuticals Ltd | COMPOSITIONS AND METHOD FOR THE TREATMENT OF INFLAMMATORY DISEASES |
EP2504311B1 (en) * | 2009-11-25 | 2015-08-12 | Cytometix, Inc. | Arachidonic acid analogs and methods for analgesic treatment using same |
CN103877100B (zh) * | 2013-05-21 | 2016-08-10 | 成都旗美健康食品有限公司 | 亚麻酸酰基乙醇胺的联合医用和保健用药物 |
EP3955747A4 (en) * | 2019-04-15 | 2023-02-01 | Metagenics, Inc. | NEW HEMP AND PEA FORMULATION AND ITS USE |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE306730B (es) * | 1963-02-06 | 1968-12-09 | Sumitomo Chemical Co | |
SE353319B (es) * | 1964-08-15 | 1973-01-29 | Sumitomo Chemical Co | |
US4619938A (en) * | 1984-03-21 | 1986-10-28 | Terumo Kabushiki Kaisha | Fatty acid derivatives of aminoalkyl nicotinic acid esters and platelet aggregation inhibitors |
NZ216751A (en) * | 1985-07-05 | 1990-01-29 | Cird | Eicosatriynoic acid esters and amides,pharmaceutical compositions and process for preparing eicosatriynoic acid |
-
1992
- 1992-11-30 IL IL10393292A patent/IL103932A/xx not_active IP Right Cessation
-
1993
- 1993-11-30 AU AU57334/94A patent/AU5733494A/en not_active Abandoned
- 1993-11-30 SK SK708-95A patent/SK70895A3/sk unknown
- 1993-11-30 WO PCT/US1993/011625 patent/WO1994012466A1/en active IP Right Grant
- 1993-11-30 HU HU9501561A patent/HUT73177A/hu unknown
- 1993-11-30 EP EP94903364A patent/EP0670826B1/en not_active Expired - Lifetime
- 1993-11-30 ES ES94903364T patent/ES2145118T3/es not_active Expired - Lifetime
- 1993-11-30 PL PL93309051A patent/PL309051A1/xx unknown
- 1993-11-30 JP JP6513466A patent/JPH08504195A/ja active Pending
- 1993-11-30 ZA ZA938947A patent/ZA938947B/xx unknown
- 1993-11-30 CN CN93121715A patent/CN1097735A/zh active Pending
- 1993-11-30 DE DE69328492T patent/DE69328492T2/de not_active Expired - Fee Related
- 1993-11-30 CZ CZ951361A patent/CZ136195A3/cs unknown
Also Published As
Publication number | Publication date |
---|---|
HUT73177A (en) | 1996-06-28 |
DE69328492T2 (de) | 2000-09-07 |
EP0670826B1 (en) | 2000-04-26 |
WO1994012466A1 (en) | 1994-06-09 |
CZ136195A3 (en) | 1995-11-15 |
IL103932A0 (en) | 1993-04-04 |
DE69328492D1 (de) | 2000-05-31 |
SK70895A3 (en) | 1995-09-13 |
EP0670826A1 (en) | 1995-09-13 |
HU9501561D0 (en) | 1995-07-28 |
ZA938947B (en) | 1994-08-02 |
IL103932A (en) | 1997-02-18 |
JPH08504195A (ja) | 1996-05-07 |
AU5733494A (en) | 1994-06-22 |
EP0670826A4 (en) | 1996-08-14 |
CN1097735A (zh) | 1995-01-25 |
PL309051A1 (en) | 1995-09-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2145118T3 (es) | Derivados de acidos grasos y composiciones farmaceuticas que los contienen. | |
ECSP941104A (es) | Derivados de 2,6 diaminopurina, procedimiento para su preparacion y composiciones farmaceuticas que los contienen | |
ES2058109T3 (es) | Un procedimiento para la preparacion de una composicion farmaceutica antimicrobiana topica. | |
ES2072323T3 (es) | Compuestos de piperidina y su preparacion y empleo. | |
AR003220A1 (es) | Derivados acilados de melatonina; composicion farmaceutica y cosmetica y el uso de los mismos para la preparacion de un medicamento. | |
ES2036593T3 (es) | Composiciones que utilizan medicamentos antiinflamatorios no esteroidales encapsulados en liposomas. | |
ES2136100T3 (es) | Composicion lipida para productos cosmeticos que contienen trigliceridos de acidos grasos insaturados. | |
ES2133575T3 (es) | Grasas para untar beneficiosas para la salud. | |
AR005703A1 (es) | Oxazolidinonas sustituidas, procedimiento para su preparacion, uso de las mismas para preparar medicamentos y medicamentos que las contienen | |
ES2174080T3 (es) | Vehiculos de principios activos a base de agentes tensioactivos no ionicos y sus aplicaciones particularmente en los ambitos alimentario, cosmetico y farmaceutico. | |
ATE55905T1 (de) | Mittel zur behandlung und zum schutz der haut. | |
ES2170141T3 (es) | 4-aminoderivados del acido micofenolico con actividad inmunosupresora. | |
ES2117052T3 (es) | Induccion de respuestas de linfocitos t citotoxicos. | |
AR008164A1 (es) | Cetolidas 6-0-sustituidas que tienen actividad antibacteriana, procedimientos para su preparacion, uso de los mismos en la preparacion decomposiciones farmaceuticas y composiciones farmaceuticas | |
ES2139132T3 (es) | Composiciones farmaceuticas activas en la terapia de desordenes del sueño. | |
ES2058799T3 (es) | Composiciones estabilizadas que contienen factor de crecimiento epidermico. | |
AR007040A1 (es) | Compuestos de eritromicina 6-0-sustituida, composiciones farmaceuticas, uso de dichos compuestos para preparar medicamentos y procedimiento para supreparacion | |
ES2171933T3 (es) | Derivados de androsteno. | |
ES2141925T3 (es) | Esteres altamente reactivos de carboxi polisacaridos y nuevos carboxi polisacaridos derivados de los mismos. | |
ES2033985T3 (es) | Un procedimiento para la preparacion de una composicion farmaceutica. | |
ES2052603T3 (es) | Derivados de bencimidazol, procedimiento para su produccion y composicion farmaceutica que los contienen. | |
IT1170214B (it) | Composizione farmaceutica per la cura delle arteriopatie periferiche | |
IT1263840B (it) | Formulazioni orali di ubidecarenone in forma di capsule | |
AR047005A1 (es) | Cuerpos de inclusion que transportan glicerol-fosfato aceptables para uso farmaceutico | |
ES2093782T3 (es) | Piridazindionas y su uso en el tratamiento de trastornos neurologicos. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 670826 Country of ref document: ES |